• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有完全2'-O-甲基核糖核苷酸修饰的正义链的小分子干扰RNA表现出依赖于AGO2/eIF2C2的活性。

Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.

作者信息

Kraynack Bryan A, Baker Brenda F

机构信息

ISIS Pharmaceuticals, Carlsbad Research Center, 1896 Rutherford Road, Carlsbad, CA 92008, USA.

出版信息

RNA. 2006 Jan;12(1):163-76. doi: 10.1261/rna.2150806. Epub 2005 Nov 21.

DOI:10.1261/rna.2150806
PMID:16301602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1370895/
Abstract

RNA interference (RNAi) is a process by which short interfering RNAs (siRNAs) direct the degradation of complementary single-strand RNAs. In this study, we investigated the effects of full-strand phosphorothioate (PS) backbone and 2'-O-methyl (2'-OMe) sugar modifications on RNAi-mediated silencing. In contrast to previous reports, we have identified active siRNA duplexes containing full 2'-OMe-modified sense strands that display comparable activity to the unmodified analog of similar sequence. The structure of these modified siRNAs is the predominant determinant of their activity, with sequence and backbone composition being secondary. We further show, by using biotin-tagged siRNAs and affinity-tagged hAgo2/eIF2C2, that activity of siRNA duplexes containing full 2'-OMe substitutions in the sense strand is mediated by the RNA-induced silencing complex (RISC) and that strand-specific loading (or binding) to hAgo2 may be modulated through selective incorporation of these modifications.

摘要

RNA干扰(RNAi)是一个过程,通过该过程,短干扰RNA(siRNA)指导互补单链RNA的降解。在本研究中,我们研究了全链硫代磷酸酯(PS)骨架和2'-O-甲基(2'-OMe)糖修饰对RNAi介导的沉默作用的影响。与之前的报道相反,我们鉴定出了活性siRNA双链体,其正义链完全由2'-OMe修饰,与相似序列的未修饰类似物表现出相当的活性。这些修饰的siRNA的结构是其活性的主要决定因素,序列和骨架组成是次要因素。我们进一步表明,通过使用生物素标记的siRNA和亲和标记的hAgo2/eIF2C2,正义链中含有完全2'-OMe取代的siRNA双链体的活性由RNA诱导沉默复合体(RISC)介导,并且通过选择性掺入这些修饰,可能会调节其与hAgo2的链特异性装载(或结合)。

相似文献

1
Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.含有完全2'-O-甲基核糖核苷酸修饰的正义链的小分子干扰RNA表现出依赖于AGO2/eIF2C2的活性。
RNA. 2006 Jan;12(1):163-76. doi: 10.1261/rna.2150806. Epub 2005 Nov 21.
2
RNA interference tolerates 2'-fluoro modifications at the Argonaute2 cleavage site.RNA干扰可耐受Argonaute2切割位点处的2'-氟修饰。
Chem Biodivers. 2007 May;4(5):858-73. doi: 10.1002/cbdv.200790073.
3
The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.人类 Argonaute2 的 5' 结合 MID 结构域耐受化学修饰的核苷酸类似物。
Nucleic Acid Ther. 2013 Feb;23(1):81-7. doi: 10.1089/nat.2012.0393. Epub 2013 Jan 5.
4
Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.小干扰RNA和短发夹RNA的序列、化学及结构变异及其对哺乳动物基因沉默的影响。
Antisense Nucleic Acid Drug Dev. 2003 Apr;13(2):83-105. doi: 10.1089/108729003321629638.
5
Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.含核糖二氟甲苯基核苷酸的寡核糖核苷酸的晶体结构、稳定性及体外RNA干扰活性:对人RNA诱导沉默复合体AGO2酶底物需求的深入了解
Nucleic Acids Res. 2007;35(19):6424-38. doi: 10.1093/nar/gkm664. Epub 2007 Sep 18.
6
Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.单链反义小干扰RNA在RNA干扰中引导靶RNA的切割。
Cell. 2002 Sep 6;110(5):563-74. doi: 10.1016/s0092-8674(02)00908-x.
7
High potency silencing by single-stranded boranophosphate siRNA.单链硼磷酸化小干扰RNA的高效沉默作用
Nucleic Acids Res. 2006 May 22;34(9):2773-81. doi: 10.1093/nar/gkl339. Print 2006.
8
Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals.在哺乳动物中,星链的切割有助于一些微小RNA组装到含Ago2的沉默复合物中。
Mol Cells. 2008 Sep 30;26(3):308-13. Epub 2008 Aug 27.
9
Both strands of siRNA have potential to guide posttranscriptional gene silencing in mammalian cells.在哺乳动物细胞中,小干扰RNA的两条链都具有引导转录后基因沉默的潜力。
PLoS One. 2009;4(4):e5382. doi: 10.1371/journal.pone.0005382. Epub 2009 Apr 29.
10
Argonaute2 is the catalytic engine of mammalian RNAi.AGO2是哺乳动物RNA干扰的催化引擎。
Science. 2004 Sep 3;305(5689):1437-41. doi: 10.1126/science.1102513. Epub 2004 Jul 29.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
siRNA-Mimetic Ratiometric pH (sMiRpH) Probes for Improving Cell Delivery and mRNA Knockdown.用于改善细胞递送和mRNA敲低的小分子干扰RNA模拟物比率型pH(sMiRpH)探针
ACS Chem Biol. 2025 Feb 21;20(2):309-320. doi: 10.1021/acschembio.4c00545. Epub 2025 Feb 5.
3
Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review.脊髓损伤修复中的巨噬细胞极化及微小RNA的潜在作用:综述
Heliyon. 2023 Nov 27;9(12):e22914. doi: 10.1016/j.heliyon.2023.e22914. eCollection 2023 Dec.
4
Emerging Progress of RNA-Based Antitumor Therapeutics.基于 RNA 的抗肿瘤治疗的新进展。
Int J Biol Sci. 2023 Jun 19;19(10):3159-3183. doi: 10.7150/ijbs.83732. eCollection 2023.
5
Ratiometric, pH-Sensitive Probe for Monitoring siRNA Delivery.用于监测 siRNA 递送的比率型、pH 敏感探针。
J Am Chem Soc. 2023 May 3;145(17):9417-9422. doi: 10.1021/jacs.3c01032. Epub 2023 Apr 19.
6
Clinical progress of nanomedicine-based RNA therapies.基于纳米医学的RNA疗法的临床进展。
Bioact Mater. 2021 Oct 22;12:203-213. doi: 10.1016/j.bioactmat.2021.10.018. eCollection 2022 Jun.
7
Nucleic Acids and Their Analogues for Biomedical Applications.核酸及其类似物在生物医学中的应用。
Biosensors (Basel). 2022 Feb 4;12(2):93. doi: 10.3390/bios12020093.
8
An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma.长链非编码 RNA 在人绒癌中的作用概述。
Int J Mol Sci. 2021 Jun 17;22(12):6506. doi: 10.3390/ijms22126506.
9
An artificial cationic oligosaccharide combined with phosphorothioate linkages strongly improves siRNA stability.一种与硫代磷酸酯键结合的人工阳离子寡糖可显著提高 siRNA 的稳定性。
Sci Rep. 2020 Sep 9;10(1):14845. doi: 10.1038/s41598-020-71896-w.
10
RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference.甲型流感病毒的RNA二级结构基序作为siRNA介导的RNA干扰的靶点
Mol Ther Nucleic Acids. 2020 Mar 6;19:627-642. doi: 10.1016/j.omtn.2019.12.018. Epub 2019 Dec 24.

本文引用的文献

1
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.TRBP将Dicer复合物招募至Ago2以进行微小RNA加工和基因沉默。
Nature. 2005 Aug 4;436(7051):740-4. doi: 10.1038/nature03868. Epub 2005 Jun 22.
2
Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions.局部RNA靶标结构影响小干扰RNA(siRNA)的功效:对特意设计的结合区域的系统分析
J Mol Biol. 2005 May 13;348(4):883-93. doi: 10.1016/j.jmb.2005.03.011.
3
Purified Argonaute2 and an siRNA form recombinant human RISC.纯化的 Argonaute2 与一种小干扰 RNA 形成重组人 RNA 诱导沉默复合体。
Nat Struct Mol Biol. 2005 Apr;12(4):340-9. doi: 10.1038/nsmb918. Epub 2005 Mar 30.
4
Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA.与未修饰的小干扰RNA相比,具有更高体外效力和稳定性的完全2'-修饰的寡核苷酸双链体。
J Med Chem. 2005 Feb 24;48(4):901-4. doi: 10.1021/jm049167j.
5
RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics.体内RNA干扰:迈向基于合成小干扰RNA的疗法。
Methods Enzymol. 2005;392:278-96. doi: 10.1016/S0076-6879(04)92016-2.
6
RNA interference and chemically modified small interfering RNAs.RNA干扰与化学修饰的小干扰RNA
Curr Opin Chem Biol. 2004 Dec;8(6):570-9. doi: 10.1016/j.cbpa.2004.10.007.
7
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.通过全身给予修饰的小干扰RNA对内源基因进行治疗性沉默。
Nature. 2004 Nov 11;432(7014):173-8. doi: 10.1038/nature03121.
8
Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity.将Argonaute 2生化鉴定为RNA诱导沉默复合体活性所需的唯一蛋白质。
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14385-9. doi: 10.1073/pnas.0405913101. Epub 2004 Sep 27.
9
Argonaute2 is the catalytic engine of mammalian RNAi.AGO2是哺乳动物RNA干扰的催化引擎。
Science. 2004 Sep 3;305(5689):1437-41. doi: 10.1126/science.1102513. Epub 2004 Jul 29.
10
Crystal structure of Argonaute and its implications for RISC slicer activity.Argonaute的晶体结构及其对RNA诱导沉默复合体(RISC)切割活性的影响。
Science. 2004 Sep 3;305(5689):1434-7. doi: 10.1126/science.1102514. Epub 2004 Jul 29.